Autolus Therapeutics Plc (AUTL)
1.755
-0.06
(-3.04%)
USD |
NASDAQ |
Oct 12, 16:00
1.77
+0.02
(+0.85%)
After-Hours: 20:00
Autolus Therapeutics Free Cash Flow (Quarterly) : -26.08M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.08M |
| March 31, 2026 | -67.89M |
| December 31, 2025 | -66.28M |
| September 30, 2025 | -79.87M |
| June 30, 2025 | -81.47M |
| March 31, 2025 | -83.81M |
| December 31, 2024 | -61.79M |
| September 30, 2024 | -86.33M |
| June 30, 2024 | -51.92M |
| March 31, 2024 | -41.05M |
| December 31, 2023 | -26.31M |
| September 30, 2023 | -41.42M |
| June 30, 2023 | -42.68M |
| March 31, 2023 | -46.46M |
| December 31, 2022 | -15.12M |
| Date | Value |
|---|---|
| September 30, 2022 | -38.70M |
| June 30, 2022 | -33.45M |
| March 31, 2022 | -35.80M |
| December 31, 2021 | -10.74M |
| September 30, 2021 | -38.61M |
| June 30, 2021 | -38.12M |
| March 31, 2021 | -39.24M |
| December 31, 2020 | -33.20M |
| September 30, 2020 | -43.11M |
| June 30, 2020 | -29.46M |
| March 31, 2020 | -26.67M |
| December 31, 2019 | -35.18M |
| September 30, 2019 | -28.27M |
| June 30, 2019 | -22.86M |
| March 31, 2019 | -33.85M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | -49.96M |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| Mereo BioPharma Group Plc | -6.049M |
| Evaxion AS | -- |